BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32365846)

  • 1. Vaccine-Mediated Mechanisms Controlling
    Lindgren H; Eneslätt K; Golovliov I; Gelhaus C; Rydén P; Wu T; Sjöstedt A
    Pathogens; 2020 Apr; 9(5):. PubMed ID: 32365846
    [No Abstract]   [Full Text] [Related]  

  • 2. An
    Golovliov I; Lindgren H; Eneslätt K; Conlan W; Mosnier A; Henry T; Sjöstedt A
    Front Cell Infect Microbiol; 2016; 6():152. PubMed ID: 27933275
    [No Abstract]   [Full Text] [Related]  

  • 3. Guanylate-Binding Proteins Are Critical for Effective Control of
    Mohammadi N; Lindgren H; Golovliov I; Eneslätt K; Yamamoto M; Martin A; Henry T; Sjöstedt A
    Front Cell Infect Microbiol; 2020; 10():594063. PubMed ID: 33363054
    [No Abstract]   [Full Text] [Related]  

  • 4. Macrophages Demonstrate Guanylate-Binding Protein-Dependent and Bacterial Strain-Dependent Responses to
    Mohammadi N; Lindgren H; Yamamoto M; Martin A; Henry T; Sjöstedt A
    Front Cell Infect Microbiol; 2021; 11():784101. PubMed ID: 35004352
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccine-Mediated Mechanisms Controlling Replication of
    Eneslätt K; Golovliov I; Rydén P; Sjöstedt A
    Front Cell Infect Microbiol; 2018; 8():27. PubMed ID: 29468144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
    Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent
    Jia Q; Horwitz MA
    Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510
    [No Abstract]   [Full Text] [Related]  

  • 8. Analyses of human immune responses to
    Lindgren H; Eneslätt K; Golovliov I; Gelhaus C; Sjöstedt A
    Front Immunol; 2023; 14():1238391. PubMed ID: 37781364
    [No Abstract]   [Full Text] [Related]  

  • 9.
    Khan H; Bhargava V; Elkins KL
    Microbiol Spectr; 2024 Jun; ():e0002824. PubMed ID: 38940590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of Francisella tularensis Intracellular Growth by Pulmonary Epithelial Cells.
    Maggio S; Takeda K; Stark F; Meierovics AI; Yabe I; Cowley SC
    PLoS One; 2015; 10(9):e0138565. PubMed ID: 26379269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria.
    Ryden P; Twine S; Shen H; Harris G; Chen W; Sjostedt A; Conlan W
    Mol Immunol; 2013 May; 54(1):58-67. PubMed ID: 23201853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis.
    De Pascalis R; Hahn A; Brook HM; Ryden P; Donart N; Mittereder L; Frey B; Wu TH; Elkins KL
    PLoS One; 2018; 13(5):e0198140. PubMed ID: 29799870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions of TolC Orthologs to
    Kopping EJ; Doyle CR; Sampath V; Thanassi DG
    Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670554
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates.
    Santiago AE; Mann BJ; Qin A; Cunningham AL; Cole LE; Grassel C; Vogel SN; Levine MM; Barry EM
    Pathog Dis; 2015 Aug; 73(6):ftv036. PubMed ID: 25986219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses.
    Twine S; Shen H; Harris G; Chen W; Sjostedt A; Ryden P; Conlan W
    Vaccine; 2012 May; 30(24):3634-45. PubMed ID: 22484348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Transcriptional and Translational Biomarkers of Tularemia Vaccine Efficacy in a Mouse Inhalation Model: Proof of Concept.
    Liu QY; Leclerc S; Pan Y; Liu Z; Stark F; Conlan JW
    Microorganisms; 2021 Dec; 10(1):. PubMed ID: 35056485
    [No Abstract]   [Full Text] [Related]  

  • 17. Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112.
    Hall JD; Woolard MD; Gunn BM; Craven RR; Taft-Benz S; Frelinger JA; Kawula TH
    Infect Immun; 2008 Dec; 76(12):5843-52. PubMed ID: 18852251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ability to Acquire Iron Is Inversely Related to Virulence and the Protective Efficacy of
    Fletcher JR; Crane DD; Wehrly TD; Martens CA; Bosio CM; Jones BD
    Front Microbiol; 2018; 9():607. PubMed ID: 29670588
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistance of Francisella tularensis strains against reactive nitrogen and oxygen species with special reference to the role of KatG.
    Lindgren H; Shen H; Zingmark C; Golovliov I; Conlan W; Sjöstedt A
    Infect Immun; 2007 Mar; 75(3):1303-9. PubMed ID: 17210667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK cells activated in vivo by bacterial DNA control the intracellular growth of Francisella tularensis LVS.
    Elkins KL; Colombini SM; Krieg AM; De Pascalis R
    Microbes Infect; 2009 Jan; 11(1):49-56. PubMed ID: 18992838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.